Snake venom induced local toxicities: Plant secondary metabolites as an auxiliary therapy

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 1, 2013, Pages 106-123

  Santhosh, M Sebastin ^a   Hemshekhar, M ^a   Sunitha, K ^a   Thushara, R M ^a   Jnaneshwari, S ^a   Kemparaju, K ^a   Girish, K S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Hyaluronidase; Local toxicity; Phytochemicals; Snake venom; SVMPs; Synthetic drugs

Indexed keywords

ANISIC ACID; ARISTOLOCHIC ACID; BERBERINE; BETULIC ACID; BETULIN; CATECHIN; CHLOROGENIC ACID; CLERODANE DERIVATIVE; CURCUMIN; GALLIC ACID; GALLIC ACID METHYL ESTER; GLUCOSIDE; GLYCOPROTEIN; HYALURONIDASE; ISOQUERCITRIN; LUPEOL ACETATE; METALLOPROTEINASE; PHOSPHOLIPASE A2; PLANT MEDICINAL PRODUCT; PTEROCARPAN DERIVATIVE; ROSMARINIC ACID; RUTOSIDE; SAPONIN; SITOSTEROL; SNAKE VENOM; STIGMASTEROL; TECTORIGENIN; TERPENOID DERIVATIVE; UNINDEXED DRUG; WEDELOLACTONE;

ARTICLE; BLEEDING; CLINICAL FEATURE; DRUG MECHANISM; EDEMA; ENVENOMATION; HUMAN; MOLECULAR DOCKING; MOLECULAR MODEL; MUSCLE NECROSIS; NONHUMAN; PROTEIN INTERACTION; TISSUE INJURY;

EID: 84875048277     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955713804484730     Document Type: Article

References (103)

1. Warrell, D.A. Snakebite. Lancet, 2010, 375, 77-88.
2. Girish, K.S.; Kemparaju, K. Overlooked issues of snakebite management: time for strategic approach. Curr. Top. Med. Chem., 2011, 11(20), 2494-508.
3. Kasturiratne, A.; Wickremasinghe, A.R.; de Silva, N.; Gunawardena, N.K.; Pathmeswaran, A.; Premaratna, R.; Savioli, L.; Lalloo, D.G.; de Silva, H.J. The global burden of snakebite: A literature analysis and modeling based on regional estimates of envenoming and deaths. PLoS. Med., 2008, 5, e218.
4. Gomes, A.; Das, R.; Sarkhel, S.; Mishra, R.; Mukherjee, S.; Bhattacharya S;, Gomes A. Herbs and herbal constituents active against snakebite. Ind. J. Expt. Biol., 2010, 48, 865-878.
5. Daltry, J.C.; Wuster, W.; Thorpe, R.S. Diet and snake venom evolution. Nature, 1996, 379, 537-540.
6. Shashidharamurthy, R.; Jagadeesha, D.K.; Girish, K.S.; Kemparaju, K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution. Mol. Cell. Biochem., 2002, 229, 93-101.
7. Aird, S.D. Ophidian envenomation strategies and the role of purines. Toxicon, 2002, 40, 335-393.
8. Girish, K.S.; Jagadeesha, D.K.; Rajeev, K.B.; Kemparaju, K. Snake venom hyaluronidase: an evidence for isoforms and extracellular matrix degradation. Mol. Cell. Biochem., 2002, 240, 105-110.
9. Girish, K.S.; Mohanakumari, H.P.; Nagaraju, S.; Vishwanath, B.S.; Kemparaju, K. Hyaluronidase and protease activity from Indian snake venoms: Neutralization by Mimosa pudica root extract. Fitoterapia, 2004, 75, 378-380.
10. Gutierrez, J.M.; Leon, G.; Lomonte, B.; Angulo, Y. Antivenoms for snakebite envenomings. Inflamm Allergy Drug Targets., 2011, 10(5), 369-80.
11. Leon, G.; Sanchez, L.; Hernandez, A.; Villalta, M.; Herrera, M.; Segura, A.; Estrada, R.; Gutierrez, J.M. Immune response towards snake venoms. Inflamm Allergy Drug Targets., 2011, 10(5), 381-98.
12. Solano, S.; Segura, A.; Leon, G.; Gutierrez, J.M.; Burnouf, T. Low pH formulation of whole IgG antivenom: Impact on quality, safety, neutralizing potency and viral inactivation. Biologicals, 2012, 40(2), 129-133.
13. Lizano, S.; Domont, G.B.; Perales, J. Natural Phospholipase A(2) myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon, 2003, 42, 963-977.
14. Quiros, S.; Alape-Giron, A.; Angulo, Y.; Lomonte, B. Isolation, characterization and molecular cloning of AnMIP, a new alphatype Phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). Comp. Biochem. Physiol B., 2007, 46, 60-68.
15. Sanchez, E.E.; Rodriguez-Acosta, A. Inhibitors of snake venoms and development of new therapeutics. Immunopharmacol Immunotoxicol, 2008, 30(4), 647-78.
16. Girish, K.S.; Kemparaju, K.; Nagaraju, S.; Vishwanath, B.S. Hyaluronidase inhibitors: a biological and therapeutic perspective. Curr. Med. Chem., 2009, 16, 2261-2288.
17. Sunitha, K.; Hemshekhar, M.; Santhosh, M.S.; Kumar, M.S.; Kemparaju, K.; Girish, K.S. Inhibition of hemorrhagic activity of viper venoms by N-acetyl cysteine: involvement of N-acetyl and thiol groups. Curr. Top Med. Chem., 2011a, 11(20), 2589-600.
18. Sunitha, K.; Hemshekhar, M.; Gaonkar, S.L.; Sebastin Santhosh, M.; Suresh Kumar, M.; Basappa.; Priya, B.S.; Kemparaju, K.; Rangappa, K.S.; Nanjunda Swamy, S.; Girish, K.S. Neutralization of haemorrhagic activity of viper venoms by 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile. Basic Clin. Pharmacol. Toxicol., 2011b, 109(4), 292-9.
19. Abu-Romman, S. Allelopathic potential of Achillea biebersteinii Afan. (Asteraceae). World Applied Sciences Journal, 2011a, 15 (7), 947-952.
20. Abu-Romman, S. Comparison of methods for isolating high quality DNA from sage (Salvia officinalis). J. Med. Plants Res., 2011(b), 5(6), 938-941.
21. Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat Rev Drug Discov., 2005, 4(3), 206-20.
22. Mann, C.D.; Neal, C.P.; Garcea, G.; Manson, M.M.; Dennison, A.R.; Berry, D.P. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur. J. Cancer Prev., 2009, 18(1), 13-25.
23. Paul, J.; Dasgupta, S. Early prediction of acute kidney injury by clinical features of snakebite patients at the time of hospital admission. N. Am. J. Med. Sci., 2012, 4(5), 216-20.
24. Martz, W. Plants with a reputation against snakebite. Toxicon, 1992, 30, 1131-1142.
25. Mors, W.B.; Nascimento, M.C.; Pereira, B.M.; Pereira, N.A. Plant natural products active against snake bite--the molecular approach. Phytochemistry, 2000, 55(6), 627-42.
26. Soares, A.M.; Ticli, F.K.; Marcussi, S.; Lourenço, M.V.; Januario, A.H.; Sampaio, S.V.; Giglio, J.R.; Lomonte, B.; Pereira, P.S. Medicinal plants with inhibitory properties against snake venoms. Curr Med Chem., 2005, 12, 2625-2641.
27. Ushanandini, S.; Nagaraju, S.; Harish Kumar, K.; Vedavathi, M.; Machiah, D.K.; Kemparaju, K.; Vishwanath, B.S.; Gowda, T.V.; Girish, K.S. The antisnake venom properties of Tamarindus indica (Leguminosae) seed extract. Phytother. Res., 2006, 20, 851-858.
28. Reid, H.A.; Thekaston, R.D.G. The management of snakebites. Bull WHO, 1983, 63, 885-895.
29. Warrell, D.A. In Clinical toxicology of snake bite in Asia; Meier, J.; White, J.; Ed.; Handbook of clinical toxicology of animal venoms and poisons. CRC Press: Boca Raton, 1995, pp 493-594.
30. Cintra-Francischinelli, M.; Caccin, P.; Chiavegato, A.; Pizzo, P.; Carmignoto, G.; Angulo, Y.; Lomonte, B.; Gutiérrez, J.M.; Montecucco, C. Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain. Proc. Natl. Acad. Sci. U.S.A., 2010, 107(32), 14140-5.
31. Rucavado, A.; Escalante, T.; Shannon, J.; Gutierrez, J.M.; Fox, J.W. Proteomics of wound exudate in snake venom-induced pathology: search for biomarkers to assess tissue damage and therapeutic success. J. Proteome Res., 2011, 10(4), 1987-2005.
32. Chaves, F.; Barboza, M.; Gutiérrez, J.M. Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon, 1995, 33(1), 31-9.
33. Gutierrez, J.M.; Rucavado, A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie, 2000, 82, 841-850.
34. Teixeira Cde, F.; Fernandes, C.M.; Zuliani, J.P.; Zamuner, S.F. Inflammatory effects of snake venom metalloproteinases. Mem Inst Oswaldo Cruz., 2005, 100, 181-184.
35. Ziolkowski, C.; Bieber, A.L. Mojave toxin affects fusion of myoblasts and viability of myotubes in cell cultures. Toxicon, 1992, 30(7), 733-44.
36. Rucavado, A.; Lomonte, B. Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon, 1996, 34(5), 567-77.
37. Gutierrez, J.M.; Lomonte, B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon, 1995, 33(11), 1405-24.
38. Salvini, T.F.; Amaral, A.C.; Miyabara, E.H.; Turri, J.A.; Danella, P.M.; Selistre de Araujo, H.S. Systemic skeletal muscle necrosis induced by crotoxin. Toxicon, 2001, 39(8), 1141-9.
39. Noble, P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix. Biol., 2002, 1, 25-29.
40. Girish, K.S.; Kemparaju, K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci., 2007, 80, 1921-1943.
41. Yingprasertchai, S.; Bunyasrisawat, S.; Ratanabanangkoon, K. Hyaluronidase inhibitors (sodium cromoglycate and sodium aurothiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms, Toxicon, 2003, 42, 635-646.
42. Girish, K.S., Kemparaju, K., Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides. Biochemistry (Moscow)., 2005, 70, 948-952.
43. Girish, K.S.; Kemparaju, K. Inhibition of Naja naja venom hyaluronidase: role in the management of poisonous bite. Life Sci., 2006, 78, 1433-1440.
44. Kemparaju, K.; Girish, K.S. Snake venom hyaluronidase: a therapeutic target. Cell Biochem Funct., 2006, 24(1), 7-12.
45. Six, D.A.; Dennis, E.A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta., 2000, 1488(1-2), 1-19.
46. Valentin, E.; Lambeau, G. What can venom phospholipases A(2) tell us about the functional diversity of mammalian secreted phospholipases A(2)? Biochimie, 2000, 82(9-10), 815-31.
47. Huang, H.C.; Lee, C.Y. Isolation and pharmacological properties of phospholipases A2 from Vipera russelli (Russell's viper) snake venom. Toxicon, 1984, 22(2), 207-17.
48. Thamaree, S.; Sitprija, V.; Leepipatpaiboon, S.; Witayalertpunya, S.; Thaworn, N. Mediators and renal hemodynamics in Russell's viper envenomation. J Nat Toxins., 2000, 9(1), 43-8.
49. Ownby, C.L.; Selistre de Araujo, H.S.; White, S.P.; Fletcher, J.E. Lysine 49 phospholipase A2 proteins. Toxicon, 1999, 37(3), 411-45.
50. Lomonte, B.; Angulo, Y.; Calderon, L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon, 2003, 42(8), 885-901.
51. Chioato, L.; Ward, R.J. Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis. Toxicon, 2003, 42(8), 869-83.
52. Watanabe, L.; Soares, A.M.; Ward, R.J.; Fontes, M.R.; Arni, R.K. Structural insights for fatty acid binding in a Lys49-phospholipase A2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid. Biochimie, 2005, 87, 161-167.
53. Deepa, M.; Gowda, T.V. Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch. Biochem. Biophys., 2002, 408(1), 42-50.
54. Chethankumar, M.; Srinivas, L. New biological activity against phospholipase A2 by Turmerin, a protein from Curcuma longa L. Biol. Chem., 2008, 389(3), 299-303.
55. Lindahl, M.; Tagesson, C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation, 1999, 21(3), 347-56.
56. 2myotoxins. Toxicon, 1999, 37(1), 199-215.
57. Melo, P.A.; do Nascimento, M.C.; Mors, W.B.; Suarez-Kurtz, G. Inhibition of the myotoxic and hemorrhagic activities of crotalid venoms by Eclipta prostrata (Asteraceae) extracts and constituents. Toxicon, 1994, 32(5), 595-603.
58. da Silva, A.J.M.; Melo, P.A.; Silva, N.M.; Brito, F.V.; Buarque, C.D.; de Souza, D.V.; Rodrigues, V.P.; Pocas, E.S.; Noel, F.; Albuquerque, E.X.; Costa, P.R. Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenation. Bioorg Med Chem Lett., 2001, 11(3), 283-6.
59. Nakagawa M.; Nakanishe K.; Darko L.L.; Vick J.A. Structures of cabenegrins A-I and A-II, potent anti-snake venoms. Tetrahedron Letters, 1982, 23, 3855-58.
60. da Silva, AJ.; Coelho, A.L.; Simas, A.B.; Moraes, R.A.; Pinheiro, D.A.; Fernandes, F.F.; Arruda, E.Z.; Costa, P.R.; Melo, P.A. Synthesis and pharmacological evaluation of prenylated and benzylated pterocarpans against snake venom. Bioorg. Med. Chem. Lett., 2004, 14(2), 431-5.
61. Vishwanath, B.S.; Fawzy, A.A.; Franson, R.C. Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation, 1988, 12(6), 549-61.
62. Chandra, V.; Jasti, J.; Kaur, P.; Srinivasan, A.; Betzel, C.H.; Singh, T.P. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure. Biochemistry, 2002, 41(36), 10914-9.
63. Ticli, F.K.; Hage, L.I.; Cambraia, R.S.; Pereira, P.S.; Magro, A.J.; Fontes, M.R.; Stabeli, R.G.; Giglio, J.R.; Franca, S.C.; Soares, A.M.; Sampaio, S.V. Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction. Toxicon, 2005, 46(3), 318-27.
64. Januario, A.H.; Santos, S.L.; Marcussi, S.; Mazzi, M.V.; Pietro, R.C.; Sato, D.N.; Ellena, J.; Sampaio, S.V.; França, S. C, Soares, A.M. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): antiproteolytic and anti-hemorrhagic properties. Chem. Biol. Interact., 2004, 150(3), 243-51.
65. Batina Mde, F.; Cintra, A.C.; Veronese, E.L.; Lavrador, M.A.; Giglio, J.R.; Pereira, P.S.; Dias, D.A.; França, S.C.; Sampaio, S.V. Inhibition of the lethal and myotoxic activities of Crotalus durissus terrificus venom by Tabernaemontana catharinensis: identification of one of the active components. Planta Med., 2000, 66(5), 424-8.
66. Bernard, P.; Scior, T.; Didier, B.; Hibert, M.; Berthon, J.Y. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A(2) inhibitors. Phytochemistry, 2001, 58(6), 865-74.
67. Nunez, V.; Castro, V.; Murillo, R.; Ponce-Soto, L.A.; Merfort, I.; Lomonte, B. Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle. Phytochemistry, 2005, 66(9), 1017-25.
68. 2inhibition by AIPLAI in vitro condition. Toxicon, 2008, 51(8):1548-53.
69. Nirmal, N.; Praba, G.O.; Velmurugan, D. Modeling studies on phospholipase A2-inhibitor complexes. Indian J. Biochem. Biophys., 2008, 45(4), 256-62.
70. Naveen Chandra, D.; Prasanth, G.K.; Nagendra Singh,; Sanjit Kumar, Jithesh, O.; Sadasivan, C.; Sujatha Sharma, Tej Singh, P.; Haridas, M. Identification of a novel and potent inhibitor of phospholipase A2 in a medicinal plant: Crystal structure at 1.93 Å and Surface Plasmon Resonance analysis of phospholipase A2 complexed with berberine. Biochimica et Biophysica Acta, 2011, 1814, 657-663.
71. Dos Santos, J.I.; Cardoso, F.F.; Soares, A.M.; Dal Pai Silva, M.; Gallacci, M.; Fontes, M.R. Structural and Functional Studies of a Bothropic Myotoxin Complexed to Rosmarinic Acid: New Insights into Lys49-PLA(2) Inhibition. PLoS One., 2011, 6(12), e28521.
72. Bjarnason, J.B.; Fox, J.W.; Hemorrhagic metalloprotease from snake venoms. Pharmacol. Ther., 1994, 62, 325-372.
73. Hite, L.A.; Jia, L.G.; Bjarnason, J.B.; Fox, J.W. cDNA sequences for four snake venom metalloproteinases: structure, classification and their relationship to mammalian reproductive proteins. Arch. Biochem. Biophys., 1994, 308, 182.
74. Kamiguti, A.S.; Zuzel, M.; Theakston, R.D. Snake venom metalloproteinases and disintegrins: interaction with cells. Braz. J. Med. Biol. Res., 1998, 31, 853-862.
75. Fox, J.W. Serrano SM. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J., 2008, 275, 3016-3030.
76. Oliveira, A.K.; Paes Leme, A.F.; Asega, A.F.; Camargo, A.C.; Fox, J.W.; Serrano, S.M. New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases. Thromb Haemost., 2010, 104, 485-497.
77. Escalante, T.; Shannon, J.; Moura-da-Silva, A.M.; Gutiérrez, J.M.; Fox, J.W. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study. Arch Biochem Biophys., 2006, 455(2), 144-53.
78. Garcia, L.T.; Parreirase Silva, L.T.; Ramos, O.H.; Carmona, A.K.; Bersanetti, P.A.; Selistre-de-Arujo, H.S. The effect of post-translational modifications on the hemorrhagic activity of snake venom metalloproteinases. Comp. Biochem. Physiol., 2004, 138, 23-32.
79. Ramos, O.H.; Selistre-de-Araujo, H.S. Comparative analysis of the catalytic domain of hemorrhage and non-hemorrhagic snake venom metallopeptidases using bioinformatic tools. Toxicon, 2004, 44, 529-538.
80. Laing, G.D.; Moura-da-Silva, A.M. Jarahagin and its multiple effects on hemostasis. Toxicon, 2005, 45, 987-996.
81. Gutierrez, J.M.; Rucavado, A.; Chaves, F.; Diaz, C.; Escalante, T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon, 2009, 54(7), 958-75.
82. Gallagher, P.; Bao, Y.; Serrano, S.M.; Liang, G.D.; Theakston, R.D.; Gutierrez, J.M.; Escalante, T.; Zigrino, P.; Moura-da-Silva, A.M.; Nischt, R.; Mauch, C.; Moskaluk, C.; Fox, J.W. Role of the snake venom toxin jarahagin in proinfllmatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. Arch. Biochem. Biophys., 2005, 441, 1-15.
83. Pinto, A.F.; Ma, L.; Dragulev, B.; Guimaraes, J.A.; Fox, J.W. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: Identification of two novel substrates with functional relevance. Arch. Biochem. Biophys., 2007, 465, 11-15.
84. Kamiguti, A.S.; Hay, C.R.M.; Theakston, R.D.G.; Zuzel, M. Insights into the mechanism of hemorrhage caused by the snake venom metalloproteinases. Toxicon, 1996, 34, 627-642.
85. da Silva, J.O.; Fernandes, R.S.; Ticli, F.K.; Oliveira, C.Z.; Mazzi, M.V.; Franco, J.J.; Giuliatti, S.; Pereira, P.S.; Soares, A.M.; Sampaio, S.V. Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba. Toxicon, 2007, 50(2), 283-91.
86. Gomes, A.; Saha, A.; Chatterjee, I.; Chakravarty, A.K. Viper and cobra venom neutralization by b-sitosterol and stigmasterol isolated from the root extract of Pluchea indica Less. (Asteraceae). Phytomed., 2007, 14, 637-643.
87. Chatterjee, I.; Chakravarty, A.K.; Gomes, A. Daboia russellii and Naja kaouthia venom neutralization by lupeol acetate isolated from the root extract of Indian sarsaparilla Hemidesmus indicus R. Br. J Ethnopharmacol., 2006, 106(1), 38-43.
88. Alam, M.I.; Gomes, A. Viper venom-induced inflammation and inhibition of free radical formation by pure compound (2-hydroxy-4-methoxy benzoic acid) isolated and purified from Anantamul (Hemidesmus indicus R. BR) root extract. Toxicon, 1998, 36(1), 207-15.
89. Pithayanukul, P.; Laovachirasuwan, S.; Bavovada, R.; Pakmanee, N.; Suttisri, R. Anti-venom potential of butanolic extract of Eclipta prostrata against Malayan pit viper venom. J. Ethnopharmacol., 2004, 90(2-3), 347-52.
90. Pithayanukul, P.; Leanpolcharenchai, J.; Saparpakorn, P. Molecular docking studies and anti-snake venom metalloproteinase activity of Thai mango seed kernel extract. Molecules, 2009, 14, 3198-3213.
91. Aung, H.T.; Nikai, T.; Niwa, M.; Takaya, Y. Rosmarinic acid in Argusia argentea inhibits snake venom-induced hemorrhage. J. Nat. Med., 2010, 64(4), 482-6.
92. Chatterjee, I.; Chakravarty, A.K.; Gomes, A. Antisnake venom activity of ethanolic seed extract of Strychnos nux vomica Linn. Indian J. Exp. Biol., 2004, 42(5), 468-75.
93. Sarkhel, S.; Chakravarty, A.K.; Das, R.; Aparna Gomes, Gomes, A. Snake venom neutralizing factor from the root extract of Emblica officinalis Linn. Orient Pharm. Exp. Med., 2011, 11, 25-33.
94. Vale, L.H.; Mendes, M.M.; Fernandes, R.S.; Costa, T.R.; S. Hage-Melim, L.I.; A. Sousa, M.; Hamaguchi, A.; Homsi-Brandeburgo, M.I.; Franca, S.C.; Silva, C.H.; Pereira, P.S.; Soares, A.M.; Rodrigues, V.M. Protective effect of Schizolobium parahyba flavonoids against snake venoms and isolated toxins. Curr. Top Med. Chem., 2011, 11(20), 2566-77.
95. Mahadeswaraswamy, Y.H.; Kumar, M.S.; Gowtham, Y.J.; Nagaraju, S.; Girish, K.S.; Kemparaju, K. The polyphenol 3, 4, 5-tri-hydroxy benzoic acid inhibits Indian Daboia russelli venom and its hemorrhagic complex induced local toxicity. Curr. Top Med. Chem., 2011a, 11(20), 2520-30.
96. Laurent, T.C.; Fraser, J.R.E. Hyaluronan. FASEB J., 1992, 6, 2397-2404.
97. Frost, G.I.; Tony, C.; Stern, R. The hyaluronidases: a chemical, biological and clinical overview. Trends. Glycosc. Glycotechnol., 1996, 8, 419-434.
98. Machiah, K.D.; Girish, K.S.; Gowda, T.V. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comp. Biochem. Physiol (Part C)., 2006, 143, 158-61.
99. Havsteen, B. Flavonoids, a class of natural products of high pharamacological potency. Biochem. Pharmacol., 1984, 32, 1141-48.
100. Hollman, P.C.H. Arts ICW. Flavonols, flavones and flavanolsnature, occurrence and dietary burden. J. Sci. Food Agricul., 2000, 80, 1081-93.
101. Kuppusamy, U.R.; Das, N.P. Inhibitory effects of flavonoids on several venom hyaluronidases. Experientia., 1991, 47, 1196-2000.
102. Kuppusamy, U.R.; Das, N.P. Protective effects of tannic acid and related natural compounds on Crotalus adamenteus subcutaneous poisoning in mice. Pharmacol. Toxicol, 1993, 72, 290-95.
103. Mahadeswaraswamy, Y.H.; Manjula, B.; Devaraja, S.; Girish, K.S.; Kemparaju, K. Daboia russelli venom hyaluronidase: purification, characterization and inhibition by β-3-(3-hydroxy-4-oxopyridyl) α-amino-propionic Acid. Curr. Top Med. Chem., 2011b, 11(20), 2556-65.